Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

AYA ALL: Real World Experience from a Tertiary Care Center in North India

Satyaranjan Das, MD, Uday Yanamandra, MBBS, Mir Moslem, MD MBBS, Rajan Kapoor, MD DM, Suman Pramanik, MD, Rajiv Kumar, MBBS, MD DM, Harshit Khurana, MD MBBS, DM, Sanjeevan Sharma, MD MBBS, Tarun Verma, MD, Singh Jasjit, MD, Ajay Sharma, MD, Velu Nair, MBBS, MD

Blood (2018) 132 (Supplement 1): 4854.

https://doi.org/10.1182/blood-2018-99-114640

Published: 2018

Journal Articles

Ph Positive ALL: Real World Experience from a Tertiary Care Center in North India

Sanjeevan Sharma, MD MBBS, Uday Yanamandra, MBBS, Mir Moslem, MD MBBS, Rajan Kapoor, MD DM, Suman Pramanik, MD, Rajiv Kumar, MBBS, MD DM, Harshit Khurana, MD, MBBS,DM, Tarun Verma, MD, Singh Jasjit, MD, Satyaranjan Das, MD, Ajay Sharma, MD, Velu Nair, MBBS, MD

Blood (2018) 132 (Supplement 1): 5901.

https://doi.org/10.1182/blood-2018-99-117861

Published: 2018

Journal Articles

Splenic Infarct As an Harbinger for Sickle Cell Traits in High Altitude

Velu Nair, MBBS, MD, Uday Yanamandra, MBBS, Rajan Kapoor, MD DM, Rajiv Kumar, MBBS, MD DM, Satya Ranjan Das, MD, Ajay Sharma, MD, Singh Jasjit, MD, Suman Pramanik, MD, Sanjeevan Sharma, MD, Tarun Verma, MD

Blood (2017) 130 (Supplement 1): 4650.

https://doi.org/10.1182/blood.V130.Suppl_1.4650.4650

Published: 2017

Journal Articles

Open Splenectomy in Chronic Immune Thrombocytopenia and Its Early Complications: Still a Safe Option in Resource Limited Setting

Rajiv Kumar, MBBS, MD DM, Divya Bansal, MD DM, Manoranjan Mahapatra, MD, Rajan Kapoor, MD DM, Pravas Mishra, MD DM, Sunil Chumber, MS

Blood (2017) 130 (Supplement 1): 4855.

https://doi.org/10.1182/blood.V130.Suppl_1.4855.4855

Published: 2017

Journal Articles

Modulation of Donor Graft By the Steroidal Lactone Withaferin A Alleviates Post-Transplant Acute GVHD Via Nrf-2 Independent T-Reg Induction

Vikram Gota, MD, Miten Mehta, PhD, Dievya Gohil, MSc, Dhruv Jha, M.Pharm, Rajiv Kumar, MBBS, MD DM, Beamon Agarwal, MD PhD, Deepak Sharma, PhD, Santosh Sandur, PhD, Navin Khattry, MD DM, Anuradha Majumdar, PhD

Blood (2017) 130 (Supplement 1): 3174.

https://doi.org/10.1182/blood.V130.Suppl_1.3174.3174

Published: 2017

Journal Articles

Cyclophosphamide Followed By Intravenous Busulfan (Cy-Bu) As Myeloablative Conditioning: Impact on Venoocclusive Disease and Transplant Outcomes, Real World Experience

Rajiv Kumar, MBBS, MD DM, Rajan Kapoor, MD DM, Satya Ranjan Das, MD, Uday Yanamandra, MBBS, Suman Pramanik, MD, Sanjeevan Sharma, MD, Singh Jasjit, MD, Tarun Verma, MD, Ajay Sharma, MD, Velu Nair, MBBS, MD

Blood (2017) 130 (Supplement 1): 3226.

https://doi.org/10.1182/blood.V130.Suppl_1.3226.3226

Published: 2017

NARROW

AYA ALL: Real World Experience from a Tertiary Care Center in North India

Ph Positive ALL: Real World Experience from a Tertiary Care Center in North India

Splenic Infarct As an Harbinger for Sickle Cell Traits in High Altitude

Open Splenectomy in Chronic Immune Thrombocytopenia and Its Early Complications: Still a Safe Option in Resource Limited Setting

Modulation of Donor Graft By the Steroidal Lactone Withaferin A Alleviates Post-Transplant Acute GVHD Via Nrf-2 Independent T-Reg Induction

Cyclophosphamide Followed By Intravenous Busulfan (Cy-Bu) As Myeloablative Conditioning: Impact on Venoocclusive Disease and Transplant Outcomes, Real World Experience

Email alerts

ASH Publications

American Society of Hematology

AYA ALL: Real World Experience from a Tertiary Care Center in North India

Ph Positive ALL: Real World Experience from a Tertiary Care Center in North India

Splenic Infarct As an Harbinger for Sickle Cell Traits in High Altitude

Open Splenectomy in Chronic Immune Thrombocytopenia and Its Early Complications: Still a Safe Option in Resource Limited Setting

Modulation of Donor Graft By the Steroidal Lactone Withaferin A Alleviates Post-Transplant Acute GVHD Via Nrf-2 Independent T-Reg Induction

Cyclophosphamide Followed By Intravenous Busulfan (Cy-Bu) As Myeloablative Conditioning: Impact on Venoocclusive Disease and Transplant Outcomes, Real World Experience

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only